Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.
Published in The lancet oncology (01.03.2022)
Published in The lancet oncology (01.03.2022)
Get full text
Journal Article
Tivozanib (T) as first-line (1L) treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in North-West of England (NWE), UK
Heseltine, Jonathan, Allison, Jennifer, Wong, Sam, Prasad, Kellati, Wong, Helen, Oong, Zhu, Charnley, Natalie, Law, Andrea, Parikh, Omi, Pillai, Manon Rhys, Waddell, Tom, Griffiths, Richard, Chow, Shien
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Tivozanib as first-line treatment of metastatic renal cell carcinoma: A real-world outcome review in North-West of England, United Kingdom
Wong, Sam, Prasad, Kellati, Waddell, Tom, Charnley, Natalie, Wong, Helen, Law, Andrea, Parikh, Omi, Pillai, Manon, Griffiths, Richard, Chow, Shien
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label phase 2 SCOPE trial
Shaw, Heather May, Patel, Poulam M., Payne, Miranda, Kumar, Satish, Danson, Sarah, Highley, Martin, Prasad, Kellati, Board, Ruth, Barlow, Clare, Larkin, James, Young, Kate, Fitzpatrick, Amanda, Karydis, Ioannis, Marples, Maria, Lee, Rebecca, Corrie, Philippa Gail, Miller, Robert, Goodhew, Georgia, Master, Fayaz, Durrant, Lindy
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Testing a prognostic model in patients with metastatic castrate resistant prostate cancer (MCRPC) treated prechemotherapy with abiraterone
Pan, Shermaine, Prasad, Kellati, Hall, Emma, Swindell, Ric, Charnley, Natalie
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
Heseltine, Jonathan, Allison, Jennifer, Wong, Sam, Prasad, Kellati, Oong, Zhu-Chuen, Wong, Helen, Law, Andrea, Charnley, Natalie, Parikh, Omi, Waddell, Tom, Chow, Shien
Published in Targeted oncology (01.07.2023)
Published in Targeted oncology (01.07.2023)
Get full text
Journal Article
Abstract CT024: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial
Shaw, Heather, Patel, Poulam, Payne, Miranda, Kumar, Satish, Highley, Martin, Prasad, Kellati, Board, Ruth, Barlow, Clare, Danson, Sarah, Miller, Robert, Goodhew, Georgia, Master, Fayaz, Durrant, Lindy
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
P-0011 Single Institutional Experience of Biodegradable Stents in Patients Receiving Non-Surgical Treatment for Oesophageal Cancer
Prasad, Kellati, Mehmood, Qurrat, Laasch, Hans-Ulrich, Mullan, Damian, Jackson, Andrew, Bhatt, Lubna, Sheikh, Hamid
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article